CYTOKINETICS, INCORPORATED Reimbursement Revenue (Deprecated 2018-01-31)
CYTOKINETICS, INCORPORATED (CYTK) reported Reimbursement Revenue (Deprecated 2018-01-31) of $3.00 thousand for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-07.
Discontinued › Income Statement › Other Income
us-gaap:ReimbursementRevenue · last filed 2012-11-07
- CYTOKINETICS, INCORPORATED reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- CYTOKINETICS, INCORPORATED reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2011-12-31 was $9.00K.
- CYTOKINETICS, INCORPORATED reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2011-09-30 was $9.00K.
- CYTOKINETICS, INCORPORATED reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2011-06-30 was $17.00K.
| Period end | Reimbursement Revenue (Deprecated 2018-01-31) 3 month | Reimbursement Revenue (Deprecated 2018-01-31) 6 month | Reimbursement Revenue (Deprecated 2018-01-31) 9 month |
|---|---|---|---|
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $3.00K 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $3.00K 10-Q · filed 2012-08-06 | ||
| 2011-12-31 | $9.00K 10-Q · filed 2012-11-07 | $18.00K derived: sum of 2 quarters · filed 2012-11-07 | $35.00K derived: sum of 3 quarters · filed 2012-11-07 |
| 2011-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $26.00K derived: sum of 2 quarters · filed 2012-11-07 | $51.00K 10-Q · filed 2012-11-07 |
| 2011-06-30 | $17.00K 10-Q · filed 2012-08-06 | $42.00K 10-Q · filed 2012-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |